|
Sertraline hydrochloride (also labeled under numerous brand names: Zoloft, Sertralin, Lustral, Apo-Sertral, Asentra, Gladem, Serlift, Stimuloton, Xydep, Serlain, Concorz) is an orally administered antidepressant of the selective serotonin reuptake inhibitor (SSRI) type. It was first approved by the Food and Drug Administration (FDA) in 1991. Invention The invention of Zoloft has been attributed to two scientists at Pfizer, Steve Werner and Billy Dzomba. At the time, the notion that the neurotransmitter serotonin and depression might be linked was a fairly new concept. Together, Wern and Bill explored a variety of potential anti-depressant compounds and, within the space of one year, developed Sertraline. Approved Sertraline is used medically mainly to treat the symptoms of depression and anxiety. It is also prescribed for the treatment of obsessive-compulsive disorder (OCD)•, post-traumatic stress disorder (PTSD)•, premenstrual dysphoric disorder (PMDD)•, panic disorder (PD)• and social phobia/social anxiety disorder•. Unapproved, off-label, and investigational Sertraline can also be used in the treatment of general anxiety disorder•, binge eating disorder •, and premature ejaculation•. There is also evidence that sertraline may be effective in the treatment of refractory neurocardiogenic syncope in children and adolescents•. A study has shown that sertraline is an effective treatment for impulsive aggressive behavior in personality disordered patients.• Side effects Sertraline can have adverse effects, including: Sleep disorder (both insomnia and increased sleep time) , asthenia, gastrointestinal complaints, tremors, confusion, dizziness, anorgasmia, nauseua/vomiting, and decreased libido; it can induce mania or hypomania in around 0.5% of patients. It has also been known to cause minor weight loss. It is contraindicated in individuals taking MAOIs or undergoing electroconvulsive therapy. It is advised you are off MAOI for at least 14 days before beginning to consume Zoloft. (http://drugs.com/zoloft.html) Until 2003, Zoloft was only approved for use in adults ages 18 and over; that year it was approved by the FDA for use in treating children ages 6 to 17 with extreme obsessive compulsive disorder. In June 2004, Britain banned Zoloft's use by minors and in February 2005, Pfizer was forced to change Zoloft's labeling to include information regarding increased incidences of suicidal behavior and depression in adolescent users of the drug. According to mentalhealth.com, Zoloft is not currently recommended or advised for use in individuals under the age of 18. After these changes, multiple incidences and at least one medical study showed an increased suicide risk in seniors who were taking Zoloft. In response to these findings, the FDA released a public health warning. This warning indicates that anyone currently using Zoloft for any reason has a greater chance of exhibiting suicidal thoughts or behaviors regardless of age. This warning is questionable, however, due to the types of illnesses Zoloft is used to treat, it is impossible to determine if these tendencies are a side effect of the drug or the illness the drug is meant to treat. Zoloft should still truly be only recommended in rather persistent cases as drugs such as these are still in the arena of the unknown. Zoloft has long been seen as the best option for breastfeeding mothers who wish to continue breastfeeding and be able to take their antidepressants. Despite its apparent safety and effectiveness during the breastfeeding period, recent studies and consumer complaints have seen a need to alter Zoloft's labeling regarding use during the third trimester of pregnancy. Though there are no teratogenetic defects associated with Zoloft, there is reason to be concerned about its effects on infants who were exposed to sertraline during the third trimester in utero. It seems that Zoloft use in late pregnancy significantly increases the potential need for hospitalization and breathing assistance in the newborn period and has also been shown to cause an increased risk of neonatal death. In light of this increased risk it is still being used due to the greater potential risk of a seriously depressed mother to herself and her fetus. Like all other medications Zoloft's use must be decided only after carefully weighing out all potential risks and benefits. Although SSRI anti-depressants may cause problems in newborn babies whose mothers took Zoloft during pregnancy, the ceasing of Zoloft consumption during pregnancy may cause a relapse of depression. If you are planning on becoming pregnant, or are currently pregnant and are taking Zoloft, do not stop taking this medication. Consult your physician first. (http://www.drugs.com/zoloft.html). According to the manufacturer's website, "if depression is left untreated, the risk of childhood suicide increases about 12 times, according to federal figures" (http://www.zoloft.com). Sertraline and other SSRIs have been shown to cause sexual side effects in both males and females taking them. While apparently uncommon, the sexual side effects caused by sertraline and other SSRIs can can last for month, years or possibly indefinitely even when the drug has been completely withdrawn. This disorder is known as Post SSRI Sexual Dysfunction. Distribution This drug has been heavily prescribed in the United States. According to one source, more than 115 million prescriptions for Sertraline had been written in the U.S. by February of 2000. The world over, $3.5 billion worth of Zoloft was sold in 2005. Formulations Sertraline is manufactured by Pfizer and sold as Zoloft in the United States as small green 25 mg tablets, blue 50 mg tablets, and yellow 100 mg tablets (Generic 100 mg sertraline tablets are also yellow), each of which is scored to allow easy halving. In the UK, the brand name is Lustral and is available in white 50 mg or 100 mg scored tablets, according to the British National Formulary (BNF). Elsewhere in the EU the brand name is Zoloft, available in white 50 mg or 100 mg scored tablets. In Australia, only the 50 mg and 100 mg strengths are available, both as white tablets. Sertraline is an odorless, white, sparingly soluble crystalline solid. The minimum effective dose is usually 50 mg per day (it can be still effective at 25 mg or 37.5 mg), but lower doses may be used in the initial weeks of treatment to acclimate the patient's body, especially the liver, to the drug and to minimize the severity of any side effects. Patients who do not experience relief of symptoms at 50 mg a day may have their dose increased, up to 200 mg a day. The patent for this brand-name drug expired in June 2006. The drug is now available in generic form in the United States. The generic version of the drug is being produced by Israeli drug maker Teva Pharmaceutical Industries Ltd. In Scandinavia a generic drug called Sertralin, manufactured by HEXAL, is available. The price differences between Zoloft and Sertralin are as much as 1.50 dollars per pill. In India, this drug is sold under the name Zosert. Green Technology? In 2002, Pfizer, inc. received an award from the U.S. Environmental Protection Agency, specifically in relation to the manufacture of Sertraline. According to the EPA, Pfizer introduced methods of production that reduced necessary inputs of raw materials and allowed for a reduction of toxic waste. These new methods have been described as more energy-efficient, permitting the company to multiply Sertraline production two-fold. Further, the application of this new process is purportedly safer for workers. Precautions Dopamine Sertraline appears to also be a minor dopamine reuptake inhibitor. At higher dosages (300 mg/day), sertraline inhibits the reuptake of dopamine as well as serotonin. Controversy In June 2003, Britain banned sertraline's use for patients under 18 years of age after studies showed a link to increasing suicidal rates. Similar concern has prevailed in the United States, where only the anti-depressant fluoxetine (another SSRI) was officially banned by the FDA for the treatment of depression in minors. However, because the antidepressant-suicide link is correlational, scientists do not know whether the increased suicide risk for people taking antidepressants occurs because the drugs make people suicidal, whether suicide occurs because the drugs un-depress the people enough to motivate the energy required to commit suicide (a popular theory), whether people statistically more likely to commit suicide are over-represented among takers of Zoloft, or because of a fourth, unknown factor. The brand-name form of setraline, Zoloft, was widely advertised to consumers as "correcting a chemical imbalance", a claim not found in the FDA-approved product labeling. Hundreds of millions of dollars were spent promoting Zoloft this way while it was still on-patent. Some have argued that this advertising may lead consumers to believe that they must take Zoloft to recover when in fact they may benefit from other non-medical treatments such as psychotherapy or exercise. In the case of Hawkins v The Commonwealth (an Australian court case from the state of New South Wales), an of Zoloft was described as an important factor in Hawkins murder (through strangling) of his wife. Hawkins had been depressed, was prescribed 50 mg of Zoloft a day and on his first day of treatment took 250 mgs. He claimed on the night of the murder that he couldn't sleep, was agitated and claimed he had hallucinations during the attack on his wife. As a result of this case Zoloft received a large amount of negative publicity, with questions being raised about it's impact on behaviour. * Discontinuation Syndrome Zoloft, along with other SSRIs, has been associated with a "cessation syndrome." This syndrome has both somatic and psychological elements, although SSRIs fall short of being classified as addictive. This non-addictive classification stems from the fact persons given the drug will not seek it out in ever-increasing quantities. Although Zoloft is defined as non-habit forming, the existence of SSRI discontinuation syndrome often necessitates a gradual tapering of one's prescribed dose when seeking to stop SSRI therapy. The prescription insert for Zoloft describes the potential side effects SSRI discontinuation as follows:
Popular culture | |||||||
|
| ||||||||
 |
|
| |